Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.

Abstract

With a growing interest of the involvement of extracellular nucleotides in both normal physiology and pathology, it has become evident that P2 receptor agonists and antagonists may have therapeutic potential. The P2Y2 receptor agonists (diquafosol tetrasodium and denufosol tetrasodium) are in the phase 3 of clinical trials for dry eye and cystic fibrosis, respectively. The thienopyridine derivatives clopidogrel and ticlopidine (antagonists of the platelet P2Y12 receptor) have been used in cardiovascular medicine for nearly a decade. Purines and pyrimidines may be of therapeutic potential also in wound healing since ATP and UTP have been shown to have many hallmarks of wound healing factors. Recent studies have demonstrated that extracellular nucleotides take part in all phases of wound repair: hemostasis, inflammation, tissue formation, and tissue remodeling. This review is focused on the potent purines and pyrimidines which regulate many physiological processes important for wound healing.

• Authors: Edyta Gendaszewska-Darmach, Marta Kucharska
• Journal: Purinergic signalling (Purinergic Signal) Vol. 7 Issue 2 Pg. 193-206 (Jun 2011) ISSN: 1573-9546 [Electronic] Netherlands
• PMID: 21519856 (Publication Type: Journal Article)